JRJames Baligeh Walter Russell

James Baligeh Walter Russell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


James Baligeh Walter Russell has a total of 168 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical, Aetiology and Temporal Trends of Hospitalised Heart Failure Patients in a Private Tertiary Hospital in Sierra Leone (2021-2025)

    by James Baligeh Walter Russell, Mohamed Smith, Yakubu Alhassan, Joshua M Coker, Edries A Tejan, Kumar Bharat, Meena Kumari, Othman Z. Mahdi, Durodami Radcliff. Lisk

    Background: Heart Failure is a complex clinical syndrome of growing public health concern in sub-Saharan Africa, yet the data from Sierra Leone are absent. The aim of the study is to characterise the clinical profile, etiological and temporal trends of hospitalised HF patients at Choithrams Memorial Hospital (CMH), Freetown, Sierra Leone, to confirm specific management strategies. Methods: This single-center, retrospective observational cohort study analysed data on HF patients (>18years) admitted at the CMH between January 2021 to 31 December 2025. The clinical definition of HF was based on the Framingham criteria and the European Society of Cardiology (ESC) guidelines , including standard echocardiographic parameters. All variables, including patients demographics, HF. phenotype, aetiology, medical history and hospital outcomes were extracted from the digital record. Non-parameteric tests, multivariable logistic regression to identify variables associated with etiology, Wilcoxon rank-sum test to compare groups and Kruskal-Wallis test to analyse trends over time were utilised. Result: A total of 765 patients were included in the study, with a median age of 53 years (IQR 42-61) and male predominance of 55.3%. Patients with recurrent HF (60.9%) were more common than those with de novo HF (39.1%), were older (54 years vs 53 years), had a higher comorbidity burden (34% vs 4%, p < 0.001), and presented with a cold-wet hemodynamic profile (18.4% vs 8.4%, p < 0.001). HFrEF (61.3%) was the most predominant phenotype, though HFpEF increased with age. Dilated Cardiomyopathy (37.0%), Hypertensive Heart Disease (31.2%) and Valvular Heart Failure (17.1%) were the leading etiologies, while ischemic heart disease (6.3%) was relatively uncommon. A majority of the patients were referred (77.9%), and 50.8% presented with NYHA IV. The strongest independent predictor for HF was hypertensive heart disease [AOR = 17.81; C.I 95%: (3.13-48.76), p 0.05 for age, sex, aetiology, and most comorbidities). Conclusion: HF affects the younger adult population in Sierra Leone and is mainly caused by DCM and HHD. The late case presentations, the high prevalence of recurrent HF, and the associated high burden of comorbidities emphasize an urgent need to develop and implement improved strategies for the prevention, early detection, and long-term management of HF within Sierra Leone's healthcare system.

  • Open Access

    Assessment of self-medication practices and safety profile of medicines utilisation among pregnant women attending antenatal clinics in Freetown, Sierra Leone: a multicentre cross-sectional study

    by Onome Thomas Abiri, Shakiratu Lawal, Joshua Coker, James Baligeh Walter Russell, Ibrahim Franklyn Kamara, N’FAlie Ibrahim Sesay, Joseph Sam Kanu, Foday Umaro Turay, Michael Lahai, Henry Edward Clarence Carter, et al.

    Despite the potential foetal and maternal risks of self-medication, studies on self-medication practice and the safety profile of medicines used during pregnancy are scarce in our setting. This study determined the self-medication practice and safety profile of medicines used among pregnant women. This cross-sectional study was conducted in face-to-face interviews among 345 pregnant women at three hospitals in Sierra Leone. Data were analysed using descriptive statistics and binary logistic regression to determine the prevalence and associated factors of self-medication. A total of 345 pregnant women participated in the study. The prevalence of self-medication prevalence among pregnant women with conventional and/or herbal medicine was 132 (38.3%). Also, 93 (75%) of the conventional medicines (CMs) were categorised as probably safe, of which paracetamol 36 (29.0%) was commonly used, followed by amoxicillin 23 (18.5%) and antimalarials 22 (17.7%) for common illnesses such as headache 30 (25.4%), urinary tract infection 23 (19.4%) and malaria 22 (18.6%). The most common reason for self-medication was previous experience with the disease 24 (27.3%). Luffa acutangula 19 (30.2%) was the most used herbal medicine (HM), and Oedema 30 (47.6%) was the most reported ailment. Among the HM users, 34 (54.0%) believe they are more effective than CMs. Secondary school education (AOR = 2.128, 95%CI = 1.191–3.804, p = 0.011), tertiary education (AOR = 2.915, 95%CI = 1.104–7.693, p = 0.031), monthly income of greater than NLe 1,000 (AOR = 4.084, 95% CI = 1.269–13.144, p = 0.018), and perceived maternal illness (AOR = 0.367, CI = 0.213–0.632, p = <0.001) were predictors of self-medication. Self-medication practice was highly prevalent and was associated with educational status, monthly income, and perceived maternal illness during pregnancy. Therefore, intervention programmes should be designed and implemented to minimise the practice and risk associated with self-medication among pregnant women.


  • Open Access

    An Assessment of Medication Errors Among Pediatric Patients in Three Hospitals in Freetown Sierra Leone: Findings and Implications for a Low-Income Country

    by Onome T Abiri, Alex Ninka, Joshua Coker, Fawzi Thomas, Isaac Smalle, Sulaiman Lakoh, Foday Turay, James Komeh, Mohamed Sesay, Joseph Sam Kanu, et al.

    Background: Pediatric patients are prone to medicine-related problems like medication errors (MEs), which can potentially cause harm. Yet, this has not been studied in this population in Sierra Leone. Therefore, this study investigated the prevalence and nature of MEs, including potential drug-drug interactions (pDDIs), in pediatric patients. Methods: The study was conducted in three hospitals among pediatric patients in Freetown and consisted of two phases. Phase one was a cross-sectional retrospective review of prescriptions for completeness and accuracy based on the global accuracy score against standard prescription writing guidelines. Phase two was a point prevalence inpatient chart review of MEs categorized into prescription, administration, and dispensing errors and pDDIs. Data was analyzed using frequency, percentages, median, and interquartile range. Kruskal–Wallis H and Mann–Whitney U-tests were used to compare the prescription accuracy between the hospitals, with p< 0.05 considered statistically significant. Results: Three hundred and sixty-six (366) pediatric prescriptions and 132 inpatient charts were reviewed in phases one and two of the study, respectively. In phase one, while no prescription attained the global accuracy score (GAS) gold standard of 100%, 106 (29.0%) achieved the 80– 100% mark. The patient 63 (17.2%), treatment 228 (62.3%), and prescriber 33 (9.0%) identifiers achieved an overall GAS range of 80– 100%. Although the total GAS was not statistically significant (p=0.065), the date (p=0.041), patient (p=< 0.001), treatment (p=0.022), and prescriber (p=< 0.001) identifiers were statistically significant across the different hospitals. For phase two, the prevalence of MEs was 74 (56.1%), while that of pDDIs was 54 (40.9%). There was a statistically positive correlation between the occurrence of pDDI and number of medicines prescribed (r=0.211, P=0.015). Conclusion: A Low GAS indicates poor compliance with prescription writing guidelines and high prescription errors. Medication errors were observed at each phase of the medication use cycle, while clinically significant pDDIs were also reported. Thus, there is a need for training on prescription writing guidelines and medication errors.


  • Open Access

    Prevalence and correlates of metabolic syndrome among adults in Freetown, Sierra Leone: A comparative analysis of NCEP ATP III, IDF and harmonized ATP III criteria

    by James Baligeh Walter Russell, Theresa Ruba Koroma, Santigie Sesay, Sallieu Kabay Samura, Sulaiman Lakoh, Ansumana Bockarie, Onome Thomas Abiri, Victor Conteh, Sorie Conteh, Mohamed Smith, et al.


  • Open Access

    Prevalence of Hypertension, awareness, treatment, and blood pressure control in Sierra Leone: A systematic review and meta-analysis

    by Theresa Ruba Koroma, James Baligeh Walter Russell, Sallieu Kabay Samura, Joshua M Coker, Sorie Conteh, George A. Yendewa, Durodami Radcliffe Lisk

    Background: In recent years, the prevalence of Hypertension (HTN) has increased in sub-Saharan countries. However, reports on the prevalence of HTN in Sierra Leone are limited. Therefore, we conducted a systematic review and meta-analysis to assess the overall estimates of the prevalence of HTN in Sierra Leone. Method: A systematic search of electronic databases (PubMed, Embase, African Journal Online and Google Scholar) was conducted by three independent investigators using keywords such as “hypertension”, “prevalence”, “blood pressure”, and “Sierra Leone”. A random-effects model was used to estimate the prevalence across studies. Heterogeneity among studies was assessed using the Cochran Q test and I 2 statistic, and publication bias was assessed using funnel plots and the Egger test. Results: We pooled the data from 15 studies (n=14,707) that met the inclusion criteria. The overall prevalence of HTN in Sierra Leone was 27.64% [95% CI = 27.45, 27.82], with significant heterogeneity observed among studies (I 2 =99.82%, p-value < 0.001). The pooled prevalence of Hypertension among males was higher than that among females (25.11% [95% CI = 24.90-25.32], I 2 =99.79%, p-value < 0.001) and 24.11% [95% CI = 23.92,24.31, I 2 =99.67%, p-value < 0.001]). The prevalence of HTN among urban residents (29.76%) was almost twice that among their rural counterparts (15.77%). Of those with HTN, 37.21% were aware of their illness, 12.87% received treatment, and only 29.73% had blood pressure control. Conclusion: More than 1 in 4 adults aged ≥ 15 years are living with HTN in Sierra Leone, with a low awareness rate and even lower treatment and control rates. Our findings highlighted the need for robust and comprehensive hypertension prevention, treatment and control policies.

  • Open Access

    Antibiotic use among hospitalised patients in Sierra Leone: a national point prevalence survey using the WHO survey methodology

    by Ibrahim Franklyn Kamara, Joseph Kanu, Anna Maruta, Bobson Derrick Fofanah, Kadijatu Nabie Kamara, Bockarie Sheriff, Victoria Katawera, Selassi A D'ALmeida, Robert Musoke, Innocent Nuwagira, et al.

    Objective Inappropriate use of antibiotics is a major driver of antibiotic resistance. A few studies conducted in Africa have documented that about half of hospitalised patients who receive antibiotics should not have received them. A few hospital-based studies that have been conducted in Sierra Leone have documented a high usage of antibiotics in hospitals. Therefore, we conducted a nationwide point prevalence survey on antibiotic use among hospitalised patients in Sierra Leone. Design We conducted a hospital-based, cross-sectional survey on the use of antibiotics using the WHO point prevalence survey methodology. Setting The study was conducted in 26 public and private hospitals that are providing inpatient healthcare services. Participants All patients admitted to paediatric and adult inpatient wards before or at 08:00 on the survey date were enrolled. Outcome measures Prevalence of antibiotic use, antibiotics Access, Watch and Reserve (AWaRe) categorisation, indication for antibiotic use prevalence and proportion of bacteria culture done. Results Of the 1198 patient records reviewed, 883 (73.7%, 95% CI 71.1% to 76.2%) were on antibiotics. Antibiotic use was highest in the paediatric wards (306, 85.7%), followed by medical wards (158, 71.2%), surgical wards (146, 69.5%), mixed wards (97, 68.8%) and lowest in the obstetrics and gynaecology wards (176, 65.7%). The most widely prescribed antibiotics were metronidazole (404, 22.2%), ceftriaxone (373, 20.5%), ampicillin (337, 18.5%), gentamicin (221, 12.1%) and amoxicillin (90, 5.0%). Blood culture was only done for one patient and antibiotic treatments were given empirically. The most common indication for antibiotic use was community-acquired infection (484, 51.9%) followed by surgical prophylaxis (222, 23.8%). Conclusion There was high usage of antibiotics in hospitals in Sierra Leone as the majority of patients admitted received an antibiotic. This has the potential to increase the burden of antibiotic resistance in the country. We, therefore, recommend the establishment of hospital antimicrobial stewardship programmes according to the WHO core components.


    • 30 November 2023
      • Vol. 40  (11) , 1209-1215

    The Stigma of Epilepsy among Patients Attending the Epilepsy Clinic at Connaught Hospital, Sierra Leone.

    by Durodami R Lisk, Alieu Kanu, James B W Russell

    Epilepsy is one of the world's most common neurological disorders with about eighty percent of cases living in low and middle-income countries. Due to superstitious cultural and traditional beliefs in Sub-Saharan Africa, the stigma associated with epilepsy is particularly disabling. Stigma negatively affects the psychosocial wellbeing of people with epilepsy (PWE) and their acceptance of medical treatment. Very limited studies have been done on the types and extent of stigma in PWE in Sierra Leone. This study will assess the extent and correlates of perceived and enacted stigma among patients attending the epilepsy clinic at Connaught hospital in Freetown, Sierra Leone. Using a semi-structured questionnaire to identify both perceived and enacted stigma, a cross-sectional descriptive study was conducted among patients attending the epilepsy clinic at Connaught hospital aged ten years and above with no major psychiatric co-morbidity. Frequency of stigma and socio-demographic and clinical correlates of stigma were determined. Of the 128 patients, (9 below 18 years) 57.8% were males. Participants had a mean age of 32.9 years. 53.9% and 79.9% of participants reported experiencing perceived and enacted stigma, respectively. Longer duration of illness and being single correlated with perceived stigma, while lower educational achievement and early age of onset of seizure correlated with enacted stigma. A seizure frequency of more than two attacks a month was significantly related to both forms of stigma. The level of epilepsy-related social stigma is high in Sierra Leone. This is likely due to poor community education, leading to misconceptions and biases. An appropriate educational intervention coupled with effective clinical management of cases is needed to mitigate epilepsy-related stigma. L'épilepsie est l'un des troubles neurologiques les plus courants dans le monde, avec environ quatre-vingts pour cent des cas vivant dans des pays à revenu faible et intermédiaire. En raison des croyances culturelles et traditionnelles superstitieuses en Afrique subsaharienne, la stigmatisation associée à l'épilepsie est particulièrement handicapante. La stigmatisation affecte négativement le bien-être psychosocial des personnes épileptiques (PWE) et leur acceptation du traitement médical. Très peu d'études ont été menées sur les types et l'étendue de la stigmatisation chez les PWE en Sierra Leone. Cette étude évaluera l'étendue et les corrélats de la stigmatisation perçue et manifeste chez les patients fréquentant la clinique de l'épilepsie à l'hôpital Connaught à Freetown, Sierra Leone. À l'aide d'un questionnaire semi-structuré pour identifier la stigmatisation perçue et manifeste, une étude descriptive transversale a été menée chez des patients fréquentant la clinique de l'épilepsie à l'hôpital Connaught, âgés de dix ans et plus, sans co-morbidité psychiatrique majeure. La fréquence de la stigmatisation et les corrélats socio-démographiques et cliniques de la stigmatisation ont été déterminés. Sur les 128 patients (9 de moins de 18 ans), 57,8% étaient des hommes. Les participants avaient un âge moyen de 32,9 ans. 53,9% et 79,9% des participants ont signalé avoir éprouvé une stigmatisation perçue et manifeste, respectivement. Une durée plus longue de la maladie et le fait d'être célibataire étaient corrélés à la stigmatisation perçue, tandis qu'un niveau d'éducation inférieur et un jeune âge de début des crises étaient corrélés à la stigmatisation manifeste. Une fréquence de crises de plus de deux attaques par mois était significativement liée aux deux formes de stigmatisation. Le niveau de stigmatisation sociale liée à l'épilepsie est élevé en Sierra Leone. Cela est probablement dû à une éducation communautaire insuffisante, conduisant à des idées fausses et des préjugés.Une intervention éducative appropriée couplée à une gestion clinique efficace des cas est nécessaire pour atténuer la stigmatisation liée à l'épilepsie. Épilepsie, Manifeste, Perçue, Stigmatisation, Sierra Leone.


  • Open Access

    Impact of COVID-19 on the Utilization of HIV Testing and Linkage Services in Sierra Leone: Experience from Three Public Health Facilities in Freetown

    by Sulaiman Lakoh, Moses M. Bangura, Olukemi Adekanmbi, Umu Barrie, Darlinda F. Jiba, Matilda N. Kamara, Daniel Sesay, Abdulai Tejan Jalloh, Gibrilla F. Deen, James B. W. Russell, et al.

    The COVID-19 pandemic adversely affected the delivery of essential health services globally. In this study, we aimed to assess the impact of the pandemic on HIV testing and linkage services at three public health facilities in Freetown, Sierra Leone. We conducted a retrospective study to assess the impact of COVID-19 on HIV testing and linkage to treatment services (HTS) at Connaught Hospital (CH-tertiary), Lumley Government Hospital (LGH-secondary) and George Brooke Community Health Center (GBC-primary) in Freetown. Statistical analyses were conducted in Stata (16.1, StataCorp LLC, College Station, TX). Intra-pandemic HTS (2020) and HTS during recovery (2021) were compared with pre-pandemic HTS (2019). Of the 8538 people tested for HIV in the three facilities, 4929 (57.5%) visited CH. Only 2249 people were tested for HIV in 2020 compared to 3825 in 2019 (difference: − 41.2%, P < 0.001). Fewer people were also tested in 2021 (difference: − 35.6% P < 0.001). The largest reductions in testing in 2020 occurred in women (− 47.7%), children under 15 (− 95.2%), married people (− 42.6%), and CH (− 46.2%). Overall, 1369 (16.0%) people were positive for HIV; CH (878, 17.9%), LGH (469, 15.6%) and GBC (22, 3.5%). The likelihood of a positive HIV test was 26% lower in 2020 than 2019 (PR 0.74; 95% CI 0.64–0.85; P < 0.001), but 16% higher in 2021 than 2019 (PR 1.16; 95% CI 1.03–1.30; P < 0.05). Of the 1369 HIV diagnosis, 526 (38.4%) were linked to care. We found significant disruptions in HIV testing and linkage services at different levels of service delivery during the COVID-19 pandemic, underscoring the need to strengthen essential health services during public health emergencies.


  • Open Access

    Prevalence and correlates of Metabolic Syndrome among adults in Freetown, Sierra Leone: A comparative analysis of NCEP ATP III, IDF and Harmonized ATP III criteria

    by James Baligeh Walter Russell, Theresa Ruba Koroma, Santigie Sesay, Sallieu K Samura, Sulaiman Lakoh, Ansumana Bockarie, Onomeh Thomas Abiri, Victor Conteh, Sorie Conteh, Mohamed Smith, et al.

    Background: Metabolic syndrome (MS) is a global health concern, especially for low and middle-income countries with limited resources and information. The study’s objective was to assess the prevalence of MS in Freetown, Sierra Leone, using the Adult Treatment Panel III (ATP III), International Diabetes Federation (IDF) and Harmonize ATP III. Additionally, we aimed to establish the concordance between these three different criteria used. Methods: This community-based health screening survey was conducted from October 2019 to October 2022. A multistage stratified random design was used to select adults aged 20 years and above. Mean, interquartile range (IQR), and logistic regression were used for statistical analysis. The kappa coefficient statistics resolved the agreement between these defined criteria. Results: The prevalence for NCEP ATP III, Harmonize ATP III and IDF criteria was 11.8% (95% CI: 9.0 - 15.15), 14.3% (95% CI: 11.3 - 18.0), and 8.5% (95% CI: 6.2 - 11.2), respectively for the 2,394 selected adults. The kappa coefficient (κ) agreement between the MS is: Harmonized ATP III and IDF criteria = [(208 (60.8%); (κ =0.62)]; Harmonized ATP III and NCEP ATP III = [(201 (58.7%); (κ =0.71)]; while IDF and NCEP ATP III was [(132 (38.6%); (κ =0.52)]. In the multivariable regression analysis, waist circumference correlated with all three MS criteria: ATP III [AOR = 0.85; C.I 95%: (0.40-1.78), p = 0.032], Harmonized ATP III [AOR = 1.14; C.I 95%: (0.62-2.11), p = 0.024], IDF [AOR = 1.06; C.I 95% (0.52-2.16), p = 0.018] Conclusion: We reported a high prevalence of MS in Freetown, Sierra Leone and identified waist circumference as a major risk factor for MS. This underscores the crucial role of health education and effective management of MS in Sierra Leone.

  • Open Access

    Prevalence of Chronic Hepatitis B Virus Infection in Sierra Leone, 1997–2022: A Systematic Review and Meta-Analysis

    by George A. Yendewa, Gi-Ming Wang, Peter B. James, Samuel P. E. Massaquoi, Sahr A. Yendewa, Manal Ghazawi, Lawrence S. Babawo, Ponsiano Ocama, James B. W. Russell, Gibrilla F. Deen, et al.

    : Hepatitis B virus (HBV) infection is a major public health problem in Sierra Leone, yet reliable estimates of cases are lacking. This study aimed to provide an estimate of the national prevalence of chronic HBV infection in the general population and select groups in Sierra Leone. We used the electronic databases PubMed/MEDLINE, Embase, Scopus, ScienceDirect, Web of Science, Google Scholar, and African Journals Online to systematically review articles reporting hepatitis B infection surface antigen seroprevalence estimates in Sierra Leone during 1997–2022. We estimated pooled HBV seroprevalence rates and assessed potential sources of heterogeneity. Of 546 publications screened, 22 studies with a total sample size of 107,186 people were included in the systematic review and meta-analysis. The pooled prevalence of chronic HBV infection was 13.0% (95% CI, 10.0–16.0) (I2 = 99%; Pheterogeneity < 0.01). During the study period, the HBV prevalence rates were as follows: 17.9% (95% CI, 6.7–39.8) before 2015, 13.3% (95% CI, 10.4–16.9) during 2015–2019, and 10.7% (95% CI, 7.5–14.9) during 2020–2022. The use of the 2020–2022 HBV prevalence estimates corresponded to 870,000 cases of chronic HBV infection (uncertainty interval, 610,000–1,213,000), or approximately one in nine people. The highest HBV seroprevalence estimates were among adolescents aged 10–17 years (17.0%; 95% CI, 8.8–30.5), Ebola survivors (36.8%; 95% CI, 26.2–48.8), people living with HIV (15.9%; 95% CI, 10.6–23.0), and those in the Northern Province (19.0%; 95% CI, 6.4–44.7) and Southern Province (19.7%; 95% CI, 10.9–32.8) regions. These findings may help inform national HBV program implementation in Sierra Leone.